Back to Authors

Fehn, Thomas

Mayo Clinic

AstraZeneca (United States)

Citations 1

Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)
Seymour, John F. , Byrd, John C. , Munir, Talha, Kater, Arnon P. , Chanan‐Khan, Asher , Furman, Richard R. , O’Brien, Susan, Brown, Jennifer R. , Mato, Anthony R. , Fehn, Thomas, Miranda, Paulo Andre P. de, Higgins, Kara, John, Ellie , Borja, Marianne de, Woyach, Jennifer A. , Byrd, John C , Ghia, Paolo , O’Brien, Susan , Stilgenbauer, Stephan , Fehn, Thomas, Jurczak, Wojciech

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7050-7052

10.1182/blood-2022-157060 Get It